CHC Healthcare Group (TPE:4164) ROCE %: 2.54% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4164 CHC Healthcare Group TPE:4164
76 GF Score
Price NT$26.05
GF Value NT$52.37
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is CHC Healthcare Group ROCE %?

CHC Healthcare Group TPE:4164 +0.19% 76 ROCE % is 2.54% as of Mar. 2026. GuruFocus rates TPE:4164 with a GF Score™ of 76/100 and a GF Value™ of NT$52.37 (Possible Value Trap). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CHC Healthcare Group's annualized ROCE % for the quarter that ended in Mar. 2026 was 2.54%.

CHC Healthcare Group  (TPE:4164) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CHC Healthcare Group ROCE % Related Terms

CHC Healthcare Group ROCE % Historical Data

* Premium members only.

The historical data trend for CHC Healthcare Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CHC Healthcare Group ROCE % Chart

CHC Healthcare Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.13 4.86 5.41 2.81 3.62

CHC Healthcare Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.61 3.05 3.93 5.39 2.54
TPE:4164
76GF Score
CHC Healthcare Group TPE:4164
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CHC Healthcare Group ROCE % Calculation

CHC Healthcare Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=428.428/( ( (14214.457 - 3493.579) + (15626.076 - 2670.093) )/ 2 )
=428.428/( (10720.878+12955.983)/ 2 )
=428.428/11838.4305
=3.62 %

CHC Healthcare Group's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=330.48/( ( (15626.076 - 2670.093) + (15956.285 - 2923.615) )/ 2 )
=330.48/( ( 12955.983 + 13032.67 )/ 2 )
=330.48/12994.3265
=2.54 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 2.54% mean?
CHC Healthcare Group (TPE:4164) has a ROCE % of 2.54% as of Mar. 2026.
Is CHC Healthcare Group's ROCE % too high?
CHC Healthcare Group's current ROCE % is 2.54%. The Medical Distribution industry median ROCE % is 9.01. CHC Healthcare Group's value of 2.54% is 71.8% below this industry median. Overall, CHC Healthcare Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's ROCE % compare to MCK and COR?
CHC Healthcare Group's ROCE % of 2.54% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.01. CHC Healthcare Group's value of 2.54% is 71.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.01, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CHC Healthcare Group's current ROCE % of 2.54% is 71.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CHC Healthcare Group's current ROCE % is 2.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$52.37, compared to a current price of NT$26.05 — trading 50.3% below its estimated fair value. The current ROCE % is 2.54% and 71.8% below the Medical Distribution industry median of 9.01. CHC Healthcare Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current ROCE % is 2.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?

Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued. The current stock price of NT$26.05 is trading 50.3% below its estimated GF Value™ of NT$52.37. GuruFocus considers CHC Healthcare Group to be Possible Value Trap.

Key valuation signals for TPE:4164:

  • ROCE %: 2.54%
  • GF Value™: NT$52.37 vs. price of NT$26.05 (50.3% below fair value)
  • GF Score™: 76/100 with 8 warning signs
  • Industry Position: 71.8% below the Medical Distribution median

No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CHC Healthcare Group Business Description

Address No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
76GF Score

Get the complete analysis for TPE:4164

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.05
Price
NT$52.37
GF Value